MANE

Conviction 64HealthcareScan · Mon, Aug 10, 2026

MANE$110.62-3.30%

ResistanceSupportVol 14

Vol MA14 914.68K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Veradermics, IncBiotechnologywww.veradermics.com ↗

Price110.62

Change-3.30%

Gap-0.83%

Rel volume1.79×

Avg volume907.84K

Avg $ vol99.01M

SMA 20109.81

SMA 50108.31

SMA 200—

Price vs 50+2.13%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 125.78

RSI (14)51

MACD hist0.06

MACD crossbull · 0d

Stoch %K / %D70 / 72

ADX (14)13

+DI / −DI18 / 19

RSI divergence—

MACD divergenceBullish

ATR %+7.35%

ADR %7.73%

52w high129.74

52w low37.03

From 52w high-14.74%

Above 52w low+198.73%

New 52w highNo

SqueezeOn · 4d

Bollinger width16.62%

%B0.54

Donchian pos46.77%

Donchian high129.80

Donchian low93.77

AVWAP (52w high)111.62

vs AVWAP high-0.89%

AVWAP (52w low)91.29

vs AVWAP low+21.18%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d1.79×

Avg vol (14d)914.68K

Avg vol (20d)907.84K

Avg $ vol (20d)99.01M

Market cap4.62B

RS 3m (vs SPY)+0.37%

RS 6m (vs SPY)+193.72%

RS line new highNo

Trend template—

Technical rank68.3

1 week+8.57%

1 month-7.51%

3 months+4.22%

6 months+187.47%

1 year—

YTD+193.03%

P/E-66.03

P/B11.83

P/S—

P/FCF-64.52

EPS-111.91

Div yield—

ROE-17.92%

ROA-17.62%

Debt/Eq—

Current59.12

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-164.25%

Price target169.20

Target upside52.96%

Analyst ratingBuy

Institutional70.62%

Ent. value4.45B

Revenue—

Net income-27.23M

Gross profit—

Free cash flow-71.63M

IndustryBiotechnology

ExchangeNYSE

Shares out41.78M

Employees21

ListedWed, Feb 4, 2026

Free float19.62M

Float %52.5%

Short interest3.94M

Days to cover7.0d

Short volume75.3%

Squeeze score97 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.32 vs −$0.56

Last surprise-135.7% miss

Setup gradeB

Conviction64 / 100

Pattern quality—

Tech rank68.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance130.52

Support90.30

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Broke out
Jun 26 – Jun 29
2 scans
→
Setting up
Jul 9
1 scan

Congress activity

Disclosed STOCK Act trades in MANE

All disclosures →

No recent disclosed trades by Congress in MANE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MANE · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Cowen Aaron Insider · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05
SUVRETTA CAPITAL MANAGEMENT, LLC Director · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Madison Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05
Cowen Aaron Insider · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Madison Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05
SUVRETTA CAPITAL MANAGEMENT, LLC Director · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05

SEC filings

EDGAR filings in MANE · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.